649 related articles for article (PubMed ID: 9815986)
1. Clinical applications of the histoculture drug response assay.
Furukawa T; Kubota T; Hoffman RM
Clin Cancer Res; 1995 Mar; 1(3):305-11. PubMed ID: 9815986
[TBL] [Abstract][Full Text] [Related]
2. Potential of the histoculture drug-response assay to contribute to cancer patient survival.
Kubota T; Sasano N; Abe O; Nakao I; Kawamura E; Saito T; Endo M; Kimura K; Demura H; Sasano H
Clin Cancer Res; 1995 Dec; 1(12):1537-43. PubMed ID: 9815954
[TBL] [Abstract][Full Text] [Related]
3. Acquisition of multidrug resistance in recurrent breast cancer demonstrated by the histoculture drug response assay.
Tanino H; Oura S; Hoffman RM; Kubota T; Furukawa T; Arimoto J; Yoshimasu T; Hirai I; Bessho T; Suzuma T; Sakurai T; Naito Y
Anticancer Res; 2001; 21(6A):4083-6. PubMed ID: 11911296
[TBL] [Abstract][Full Text] [Related]
4. [Chemosensitivity test for gastric carcinoma].
Kubota T
Gan To Kagaku Ryoho; 1997 Feb; 24(4):495-500. PubMed ID: 9063490
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin sensitivity of ovarian cancer in the histoculture drug response assay correlates to clinical response to combination chemotherapy with cisplatin, doxorubicin and cyclophosphamide.
Ohie S; Udagawa Y; Kozu A; Komuro Y; Aoki D; Nozawa S; Moossa AR; Hoffman RM
Anticancer Res; 2000; 20(3B):2049-54. PubMed ID: 10928150
[TBL] [Abstract][Full Text] [Related]
6. Clinical Correlation of the Histoculture Drug Response Assay in Gastrointestinal Cancer.
Hoffman RM
Methods Mol Biol; 2018; 1760():61-72. PubMed ID: 29572794
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the histoculture drug response assay as a sensitivity test for anticancer agents.
Suda S; Akiyama S; Sekiguchi H; Kasai Y; Ito K; Nakao A
Surg Today; 2002; 32(6):477-81. PubMed ID: 12107769
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of optimal drug concentration in histoculture drug response assay in association with clinical efficacy for head and neck cancer.
Hasegawa Y; Goto M; Hanai N; Ijichi K; Adachi M; Terada A; Hyodo I; Ogawa T; Furukawa T
Oral Oncol; 2007 Sep; 43(8):749-56. PubMed ID: 17112769
[TBL] [Abstract][Full Text] [Related]
9. An anticancer drug sensitivity test to determine the effectiveness of UFT as postoperative adjuvant chemotherapy for patients with stage III colorectal cancer.
Isogai A; Nagaya M; Matsuoka H; Watanabe T; Tsukikawa S; Kubota S
Surgery; 2007 Nov; 142(5):741-8. PubMed ID: 17981195
[TBL] [Abstract][Full Text] [Related]
10. [The effect of the histoculture drug response assay (HDRA) based perioperative chemotherapy for non-small cell lung cancer].
Tanahashi M; Yamada T; Moriyama S; Suzuki E; Niwa H
Kyobu Geka; 2008 Jan; 61(1):26-30. PubMed ID: 18186269
[TBL] [Abstract][Full Text] [Related]
11. Chemosensitivity of breast cancer lymph node metastasis compared to the primary tumor from individual patients tested in the histoculture drug response assay.
Furukawa T; Kubota T; Tanino H; Oura S; Yuasa S; Murate H; Morita K; Kozakai K; Yano T; Hoffman RM
Anticancer Res; 2000; 20(5C):3657-8. PubMed ID: 11268434
[TBL] [Abstract][Full Text] [Related]
12. Clinical studies on a new screening assay for anticancer agents using nude mice and isotopic evaluation.
Noso Y; Niimi K; Nishiyama M; Hirabayashi N; Toge T; Niimoto M; Hattori T
Cancer Res; 1987 Dec; 47(23):6418-22. PubMed ID: 3677085
[TBL] [Abstract][Full Text] [Related]
13. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
[TBL] [Abstract][Full Text] [Related]
15. Multicenter randomized prospective study of adjuvant chemotherapy with UFT and mitomycin C in advanced colorectal cancer.
Nakagoe T; Ishikawa H; Sawai T; Tuji T; Ayabe H; Eida K; Nogawa T; Nakamura Y; Kunisaki T; Tobinaga K; Furukawa M; Ino M
Anticancer Res; 2000; 20(2B):1069-75. PubMed ID: 10810399
[TBL] [Abstract][Full Text] [Related]
16. Repeated hepatic intra-arterial chemotherapy based on results of anticancer drug sensitivity test in patients with synchronous hepatic metastases from colorectal cancer.
Matsuoka H; Nagaya M; Tsukikawa S; Yanagi Y; Isogai A; Kubota S
Surgery; 2006 Sep; 140(3):387-95. PubMed ID: 16934600
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant chemotherapy followed by salvage surgery: effect on survival of patients with primary noncurative gastric cancer.
Yano M; Shiozaki H; Inoue M; Tamura S; Doki Y; Yasuda T; Fujiwara Y; Tsujinaka T; Monden M
World J Surg; 2002 Sep; 26(9):1155-9. PubMed ID: 12209246
[TBL] [Abstract][Full Text] [Related]
18. Prospective correlative chemosensitivity testing in high-dose intraarterial chemotherapy for liver metastases.
Link KH; Aigner KR; Kuehn W; Schwemmle K; Kern DH
Cancer Res; 1986 Sep; 46(9):4837-40. PubMed ID: 3731130
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies of in vitro chemosensitivity test evaluated by ATP assay of gastrointestinal cancer].
Jinushi K; Hirabayashi N; Kirihara Y; Takagami S; Ryuji K; Yorishima T; Nishiyama M; Noso Y; Toge T
Gan To Kagaku Ryoho; 1990 Nov; 17(11):2235-9. PubMed ID: 2122811
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of chemotherapy based on an in vitro chemosensitivity test in urothelial cancer patients.
Hirano Y; Kageyama S; Ushiyama T; Suzuki K; Fujita K
Anticancer Res; 2001; 21(6A):4061-6. PubMed ID: 11911292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]